MAEVE
Microbiota Mediated Flavonoid Metabolites for Cognitive Health (MAEVE) Study
Purpose
The MAEVE study is a multi-center, randomized, double-blind, placebo-controlled study for cognitively normal older adults at enhanced risk of developing Alzheimer’s Disease (AD). The study seeks to enroll individuals who are aged 50+, have an immediate family member with AD, and have a BMI ≥ 25.0. Those who participate will have:
- 4 in-person appointments over 1 year. Visits include MRIs, cognitive testing, and blood draws.
- Monthly online questionnaires
- Nutritionist consults
(Principal Investigator: Arpana Church, PhD / Co-Investigator: Keith Vossel, MD, MSc)
Contact: Karen Elrayes at (310) 206-1822 or KElrayes@mednet.ucla.edu, or Marika Dy at (310) 2267-0089 or ChurchLab@mednet.ucla.edu to participate in this study or for more information.